STOCK TITAN

Else Nutrition Announces CSE Conditional Approval

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Positive)
Tags

Else Nutrition (OTCQX:BABYF) received conditional approval to list its common shares on the Canadian Securities Exchange (CSE). The listing remains subject to CSE approval and customary conditions, with no assurance it will be obtained.

The company plans US$310,000 in additional funding with Lind Global Fund III LP, a 10-for-1 share consolidation, and settlement of $207,000 of debt via common shares at a post-consolidated price of $0.15 per share. Else Nutrition is targeting July 7 for trading commencement on the CSE, conditional on final filings, financing, debt settlement and consolidation.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • Conditional approval obtained to list common shares on the CSE
  • Planned additional US$310,000 funding with Lind Global Fund III LP
  • Plan to settle $207,000 of debt through share issuance
  • Targeted CSE trading start date of July 7, subject to conditions

Negative

  • CSE listing remains conditional with no assurance of final approval
  • 10-for-1 share consolidation required for CSE listing
  • Debt settlement via new shares implies equity dilution for existing holders
  • Completion of financing, debt settlement and consolidation required before CSE trading
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

VANCOUVER, BC, June 29, 2026 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL) (the "Company") is pleased to announce that it has received conditional approval to list its common shares on the Canadian Securities Exchange (the "CSE").

In connection with the conditional listing, the Company is working to complete an additional funding of US$310,000 with Lind Global Fund III LP.  Listing on the CSE also remains subject to the approval of the CSE and the satisfaction of customary listing conditions, and there can be no assurance that such listing will be obtained.

In connection with the listing on the CSE, the Company will complete a share consolidation on the basis of 10 existing shares for each 1 new share. In addition the Company will settle $207,000 of debt by issuing common shares at a post-consolidated price of $0.15 per share. 

The Company is targeting a trading date of July 7 for the commencement of trading on the CSE, subject to meeting completing final filings with the CSE, and completing the above noted financing, debt settlement and the share consolidation.

About Else Nutrition Holdings Inc.

Else Nutrition Holdings Inc. is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.

Awards and Recognition:

  • "2017 Best Health and Diet Solutions" award at Milan's Global Food Innovation Summit
  • #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category
  • "Best Dairy Alternative" Award 2021 at World Plant-Based Expo
  • Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category
  • During September 2022, Else Super Cereal reached the #1 Best Seller in Baby Cereal across all brands on Amazon

For more information, visit www.elsenutrition.com or @elsenutrition on Facebook and Instagram.

Neither the TSX nor its regulation services provider (as that term is defined in the policies of the TSX) accept responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this press release include statements with respect to the Company's application to list its common shares on the CSE, the receipt of approval of the CSE listing application, obtaining funding from Lind Global Fund III LP, the continued trading of the Company's common shares and warrants on the TSX pending such listing, and the delisting of the Company's common shares and warrants from the TSX. Such forward-looking statements reflect current estimates, beliefs, and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Actual results may differ from the estimates, beliefs, and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/else-nutrition-announces-cse-conditional-approval-302812798.html

SOURCE Else Nutrition Holdings Inc.

FAQ

What did Else Nutrition (OTCQX:BABYF) announce about its CSE listing on June 29, 2026?

Else Nutrition announced it received conditional approval to list its common shares on the Canadian Securities Exchange. According to the company, the listing still requires CSE approval and satisfaction of customary conditions, and there is no assurance that the CSE listing will ultimately be obtained.

When is Else Nutrition targeting the start of CSE trading for BABYF shares?

Else Nutrition is targeting a July 7 commencement date for trading on the Canadian Securities Exchange. According to the company, this target depends on completing final CSE filings, closing the US$310,000 financing, executing the $207,000 debt settlement, and finalizing the 10-for-1 share consolidation.

What is the 10-for-1 share consolidation Else Nutrition plans for its CSE listing?

Else Nutrition plans a 10-for-1 share consolidation, exchanging ten existing shares for one new share. According to the company, this consolidation is part of the conditions connected to the CSE listing and will precede trading, affecting share count but not total shareholder value proportionally.

How much new funding is Else Nutrition arranging with Lind Global Fund III LP?

Else Nutrition is working to complete additional funding of US$310,000 with Lind Global Fund III LP. According to the company, this financing is connected to the conditional CSE listing and is one of the steps required before trading can begin on the Canadian Securities Exchange.

How will Else Nutrition settle $207,000 of debt as part of its CSE listing plans?

Else Nutrition intends to settle $207,000 of debt by issuing common shares at a post-consolidated price of $0.15. According to the company, this debt settlement will occur in connection with the CSE listing and follows the planned 10-for-1 share consolidation.

What conditions must Else Nutrition meet before BABYF can begin trading on the CSE?

Else Nutrition must obtain final CSE approval and satisfy customary listing conditions before trading can start. According to the company, it also needs to complete the US$310,000 financing, execute the $207,000 debt settlement, finalize the 10-for-1 consolidation, and complete required CSE filings.